197 related articles for article (PubMed ID: 20227266)
1. Expression of hepatitis B virus surface antigen determinants in Lactococcus lactis for oral vaccination.
Zhang Q; Zhong J; Huan L
Microbiol Res; 2011 Feb; 166(2):111-20. PubMed ID: 20227266
[TBL] [Abstract][Full Text] [Related]
2. Oral delivery of wafers made from HBsAg-expressing maize germ induces long-term immunological systemic and mucosal responses.
Hayden CA; Fischer ME; Andrews BL; Chilton HC; Turner DD; Walker JH; Tizard IR; Howard JA
Vaccine; 2015 Jun; 33(25):2881-6. PubMed ID: 25944300
[TBL] [Abstract][Full Text] [Related]
3. [Impact of different adjuvants on immunogenicity of the HBV particle vaccine containing the S + preS1 fusion antigen in Balb/C mice].
Chen H; Deng Y; Tan W; Wang W; Yin X; Guan J; Wang W; Ruan L
Sheng Wu Gong Cheng Xue Bao; 2010 Jan; 26(1):74-8. PubMed ID: 20353095
[TBL] [Abstract][Full Text] [Related]
4. Development of a more efficient hepatitis B virus vaccine by targeting hepatitis B virus preS to dendritic cells.
Jing M; Wang J; Zhu S; Ao F; Wang L; Han T; Yue X; Zhu Y; Ye L; Liu S
Vaccine; 2016 Jan; 34(4):516-522. PubMed ID: 26686999
[TBL] [Abstract][Full Text] [Related]
5. Recombinant Semliki Forest virus vectors encoding hepatitis B virus small surface and pre-S1 antigens induce broadly reactive neutralizing antibodies.
Niedre-Otomere B; Bogdanova A; Skrastina D; Zajakina A; Bruvere R; Ose V; Gerlich WH; Garoff H; Pumpens P; Glebe D; Kozlovska T
J Viral Hepat; 2012 Sep; 19(9):664-73. PubMed ID: 22863271
[TBL] [Abstract][Full Text] [Related]
6. Oral immunization with recombinant hepatitis E virus antigen displayed on the Lactococcus lactis surface enhances ORF2-specific mucosal and systemic immune responses in mice.
Gao S; Li D; Liu Y; Zha E; Zhou T; Yue X
Int Immunopharmacol; 2015 Jan; 24(1):140-5. PubMed ID: 25445956
[TBL] [Abstract][Full Text] [Related]
7. Broadly protective immunity against divergent influenza viruses by oral co-administration of Lactococcus lactis expressing nucleoprotein adjuvanted with cholera toxin B subunit in mice.
Lei H; Peng X; Jiao H; Zhao D; Ouyang J
Microb Cell Fact; 2015 Aug; 14():111. PubMed ID: 26242406
[TBL] [Abstract][Full Text] [Related]
8. Protection against human papillomavirus type 16-induced tumors in C57BL/6 mice by mucosal vaccination with Lactococcus lactis NZ9000 expressing E6 oncoprotein.
Taghinezhad-S S; Mohseni AH; Keyvani H; Razavilar V
Microb Pathog; 2019 Jan; 126():149-156. PubMed ID: 30391536
[TBL] [Abstract][Full Text] [Related]
9. Immune responses to recombinant Mycobacterium smegmatis expressing fused core protein and preS1 peptide of hepatitis B virus in mice.
Yue Q; Hu X; Yin W; Xu X; Wei S; Lei Y; Lü X; Yang J; Su M; Xu Z; Hao X
J Virol Methods; 2007 Apr; 141(1):41-8. PubMed ID: 17197041
[TBL] [Abstract][Full Text] [Related]
10. Age-dependent systemic antibody responses and immunisation-associated changes in mice orally and nasally immunised with Lactococcus lactis expressing a malaria parasite protein.
Moorthy SA; Yasawardena SG; Ramasamy R
Vaccine; 2009 Aug; 27(36):4947-52. PubMed ID: 19545652
[TBL] [Abstract][Full Text] [Related]
11. Oral immunization with recombinant Lactococcus lactis delivering a multi-epitope antigen CTB-UE attenuates Helicobacter pylori infection in mice.
Li X; Xing Y; Guo L; Lv X; Song H; Xi T
Pathog Dis; 2014 Oct; 72(1):78-86. PubMed ID: 24687988
[TBL] [Abstract][Full Text] [Related]
12. [Immune response in mice induced by the fusion protein of HBcAg and HBV PreS1].
Chen XC; Zhou BP; Li MZ; Wang ZX; Wang HS; Zhang B; Tang W
Zhonghua Gan Zang Bing Za Zhi; 2003 Mar; 11(3):184-5. PubMed ID: 12681075
[No Abstract] [Full Text] [Related]
13. Production of a particulate hepatitis C vaccine candidate by an engineered Lactococcus lactis strain.
Parlane NA; Grage K; Lee JW; Buddle BM; Denis M; Rehm BH
Appl Environ Microbiol; 2011 Dec; 77(24):8516-22. PubMed ID: 21984246
[TBL] [Abstract][Full Text] [Related]
14. Recombinant interleukin 6 with M cell-targeting moiety produced in Lactococcus lactis IL1403 as a potent mucosal adjuvant for peroral immunization.
Li HS; Piao DC; Jiang T; Bok JD; Cho CS; Lee YS; Kang SK; Choi YJ
Vaccine; 2015 Apr; 33(16):1959-67. PubMed ID: 25738814
[TBL] [Abstract][Full Text] [Related]
15. Oral immunization with recombinant Lactococcus lactis expressing the hemagglutinin of the avian influenza virus induces mucosal and systemic immune responses.
Wang Z; Gao J; Yu Q; Yang Q
Future Microbiol; 2012 Aug; 7(8):1003-10. PubMed ID: 22913358
[TBL] [Abstract][Full Text] [Related]
16. Immunization with r-Lactococcus lactis expressing outer membrane protein A of Shigella dysenteriae type-1: evaluation of oral and intranasal route of administration.
Yagnik B; Sharma D; Padh H; Desai P
J Appl Microbiol; 2017 Feb; 122(2):493-505. PubMed ID: 27860045
[TBL] [Abstract][Full Text] [Related]
17. Oral vaccination with Lactococcus lactis expressing the Vibrio cholerae Wzm protein to enhance mucosal and systemic immunity.
Zamri HF; Shamsudin MN; Rahim RA; Neela V
Vaccine; 2012 May; 30(21):3231-8. PubMed ID: 22426330
[TBL] [Abstract][Full Text] [Related]
18. High immunogenicity of a hydrophilic component of the hepatitis B virus preS1 sequence exposed on the surface of three virus-like particle carriers.
Skrastina D; Bulavaite A; Sominskaya I; Kovalevska L; Ose V; Priede D; Pumpens P; Sasnauskas K
Vaccine; 2008 Apr; 26(16):1972-81. PubMed ID: 18343539
[TBL] [Abstract][Full Text] [Related]
19. Lactococcus-based vaccine against brucellosis: IgG immune response in mice with rOmp16-IL2 fusion protein.
Rezaei M; Rabbani-Khorasgani M; Zarkesh-Esfahani SH; Emamzadeh R; Abtahi H
Arch Microbiol; 2021 Jul; 203(5):2591-2596. PubMed ID: 33689001
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of oral vaccination with Lactococcus lactis derived vaccine candidate antigen (UreB) of Helicobacter pylori fused with the human interleukin 2 as adjuvant.
Zhang HX; Qiu YY; Zhao YH; Liu XT; Liu M; Yu AL
Mol Cell Probes; 2014 Feb; 28(1):25-30. PubMed ID: 24036137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
